State of Cell Therapy in Multiple Myeloma: Nina Shah, MD

The hematologist and oncologist from University of California, San Francisco discussed the current state of cellular therapy in multiple myeloma.

MD Anderson to Offer Solutions to Cell Therapy AEs

The new technologies were made available as a result of the licensing agreement between MD Anderson and Bellicum Pharmaceuticals.

Updated KarMMA Data of Ide-Cel in Multiple Myeloma: Larry D. Anderson Jr, MD, PhD

The associate professor from the Harold C. Simmons Comprehensive Cancer Center of UT Southwestern Medical Center discussed the latest data from the KarMMA trial.